Award
Purchase Order #36C26326P0502
TAVR Device Procurement by Edwards Lifesciences LLC
Buyer
Department of Veterans Affairs
Award Amount
$34,000.00
Ceiling
$34,000.00
Awarded
May 29, 2026
Period of Performance
May 29, 2026 – Jun 01, 2026
Identifier
36C26326P0502
NAICS
339113
This award represents a purchase order contract granted to Edwards Lifesciences LLC, a company specializing in medical technologies and devices related to heart valve therapies. The contract involves the procurement of Transcatheter Aortic Valve Replacement (TAVR) products, which are innovative medical devices used in minimally invasive heart valve replacement procedures. The procurement holds significance for enhancing the agency's capabilities in deploying cutting-edge cardiac treatment options. The scope of work covers the delivery of TAVR devices intended for medical use within the Minneapolis area. This award follows a competitive process suited to meet specific clinical requirements, ensuring quality and reliability. The contract is set for a short-term performance window spanning a few days in late spring of 2026. While modest in scale, this timely acquisition supports ongoing advances in cardiovascular healthcare technology.
Description
TAVR